Choosing a training-data partner is the least glamorous decision in AI, and the one most likely to sink a project before the model ever sees production. The question posted here, about separating vendors who deliver real volume from those who just market it well, is exactly the right one to ask. The uncomfortable truth is that most annotation providers are not in the business of scale; they are in the business of appearing scalable. A website with enterprise logos and a polished dashboard tells you nothing about whether a team can ship two million labeled samples on a Tuesday, with consent documentation intact and labeling consistency that holds up across shifts.
The instinct to test with a trial batch is sound, but the trial itself needs to be designed like a miniature version of the full contract. That means giving the vendor a slice of your hardest data, not your easiest. It means checking turnaround time under a tight deadline, not the comfortable window they propose. And it means reviewing labels for edge cases, not just overall accuracy, because uneven labeling tends to hide in the corners of a dataset. As we noted in Clean Data Starts With Catching AI Slop Before It Skews Your Model, the failure modes that corrupt models are rarely the obvious ones. The same logic applies here: a vendor that nails your pilot on clean, well-lit images may fall apart on ambiguous, noisy, real-world samples.
The warning signs the questioner lists, late deliveries, uneven labeling, vague sourcing and consent practices, are all red flags, but the most telling one is vague consent. If a partner cannot articulate exactly where their data comes from and what rights they hold, that problem will not surface at the trial stage. It will surface later, in a compliance review or a customer audit, and by then you are not just re-labeling data, you are re-architecting your pipeline. This is the same lesson from When you shift marketing spend, does your MMM finally tell the truth?: the information you fail to collect at the start is the information you cannot recover later.
On the question of one major vendor versus several smaller teams, the answer depends on what you are optimizing for. A single large vendor offers consistency of process, but it also concentrates risk. If their labeling quality drifts mid-contract, you have no fallback. Splitting work across two or three smaller teams creates redundancy, but it requires you to invest in your own quality arbitrage, comparing labels across teams and resolving disagreements. That is real work, and it is work most teams are not staffed for. The pragmatic path is to run a competitive trial with two or three candidates, not just one, and keep a smaller backup team engaged even after you select a primary. The cost of that backup is trivial compared to the cost of a stalled delivery.
The most practical takeaway here is to demand a reference, not a portfolio. Ask any serious provider for a past project of comparable volume and a contact who will speak candidly about what went wrong. If they hesitate, that is your answer. The market is full of vendors who can show you beautiful case studies and then miss a deadline by six weeks. The ones worth hiring will be happy to put you in touch with a customer who will tell you how they handled the ugly parts. That conversation, more than any trial batch, will tell you whether they deliver at scale or just on paper. And when you make your choice, posting it publicly, as the questioner plans to do, is the kind of transparency this industry desperately needs.